Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 6.32 MB)

  Published:

  01 November 2023

• Final draft guidance committee papers (PDF 5.38 MB)

  Published:

  01 November 2023